Articles

Influence of molecular subgroups on outcome of acute myeloid leukemia with normal karyotype in 141 patients undergoing salvage allogeneic stem cell transplantation in primary induction failure or beyond first relapse

Department of Hematology and Oncology, Klinikum Augsburg, Germany
Deutsche Klinik für Diagnostik, Wiesbaden, Germany
Department of Hematology and Oncology, Masaryk University Hospital, Brno, Czech Republic
Department of Anesthesiology, Critical Care Medicine and Medical Statistics, Klinikum Augsburg, Germany
Department of Hematology and Oncology, Ludwig-Maximilians-University Hospital, Munich, Germany
Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany
Department of Hematology and Oncology, University Hospital, Ulm, Germany
Department of Medicine II, Hematology/Oncology, Goethe University Hospital, Frankfurt a. M., Germany
Dept. of Hematology and Oncology, University Hospital, Regensburg, Germany
University Medical Center, Department of Hematology, Oncology and Pneumology, Mainz, Germany
Department of Hematology and Oncology, BMT Unit, Medical University of Vienna, Austria
Department of Hematology and Oncology, University Hospital, Cologne, Germany
State Center of Gene and Cell Therapy, Martin-Luther-University Halle/Wittenberg, Halle, Germany
MLL Munich Leukemia Laboratory, Munich, Germany
Department of Hematology and Oncology, Krankenhaus der Barmherzigen Brüder, Regensburg, Germany
Department of Hematology and Oncology, Klinikum Augsburg, Germany
Department of Hematology and Oncology, Ludwig-Maximilians-University Hospital, Munich, Germany
Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany
Department of Medicine, Hematology/Oncology, Technische Universität München, Munich, Germany
Department of Hematology and Oncology, Klinikum Augsburg, Germany
Vol. 98 No. 4 (2013): April, 2013 https://doi.org/10.3324/haematol.2012.070235